Objectives: Since 1979, a number of publications have appeared regarding complications of laser surgery of the larynx. Most publications focus on complications such as accidental burns, rouse of the ventilation tube, anesthesiologic problems, edema of the mucosa, and abnormal scar formation. Secondary hemorrhage has played a subordinate role and cases demanding postoperative treatment have only been reported sporadically. All cases occurred within the first postoperative week, and no case resulting in death has been reported. The aim of the article is to draw attention to the fact that after laser surgery of the larynx, late lethal secondary hemorrhage may occur. Material and Patients: We review the literature and describe a patient in whom a lethal secondary hemorrhage occurred 10 days after laser supraglottic laryngectomy. The case is analyzed and similarities to hemorrhages associated with tonsillectomy and laser surgery of the lingual tonsil are shown. Results and Conclusions: The risk of very late severe secondary hemorrhage after laryngeal laser surgery is considered to be very seldom and comparable with that after tonsillectomy. Due to the increase in laser application in the treatment of laryngeal carcinoma, secondary hemorrhage may be encountered. Consequences for preoperative information and postoperative control of the patients have to be discussed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.